The control of labor

New England Journal of Medicine

Volumn 341, Issue 9, 1999, Pages 660-666

  Norwitz, Errol R ^a   Robinson, Julian N ^a   Challis, John R G ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; FENOPROFEN; INDOMETACIN; ISOXSUPRINE; LEMAKALIM; MAGNESIUM SULFATE; NAPROXEN; NICARDIPINE; NIFEDIPINE; OXYTOCIN ANTAGONIST; PHOSPHODIESTERASE INHIBITOR; POTASSIUM CHANNEL STIMULATING AGENT; PROSTAGLANDIN INHIBITOR; RITODRINE; SALBUTAMOL; TERBUTALINE SULFATE; UNINDEXED DRUG; UTERUS SPASMOLYTIC AGENT; VERAPAMIL;

DRUG APPROVAL; DRUG INDUCED DISEASE; HORMONAL REGULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION; TOCOLYSIS; TRANSDERMAL DRUG ADMINISTRATION; UTERUS CONTRACTION;

EID: 0033606915     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199908263410906     Document Type: Review

References (70)

1. Nathanielsz PW, Giussani DA, Wu WX. Stimulation of the switch in myometrial activity from contractures to contractions in the pregnant sheep and nonhuman primate. Equine Vet J Suppl 1997;24:83-8.
2. Duff P, Huff RW, Gibbs RS. Management of premature rupture of membranes and unfavorable cervix in term pregnancy. Obstet Gynecol 1984;63:697-702.
3. López Bernal A, Rivera J, Europe-Finner GN, Phaneuf S, Asboth G. Parturition: activation of stimulatory pathways or loss of uterine quiescence? Adv Esp Med Biol 1995;395:435-51.
4. Garrioch DB. The effect of indomethacin on spontaneous activity in the isolated human myometrium and on the response to oxytocin and prostaglandin. Br J Obstet Gynaecol 1978;85:47-52.
5. Challis JRG, Gibb W. Control of parturition. Prenat Neonat Med 1996; 1:283-91.
6. Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC III. Williams obstetrics. 19th ed, Nonwalk, Conn.: Appleton & Lange, 1993:298-9.
7. Garfield RE, Blennerhassett MG, Miller SM. Control of myometrial contractility: role and regulation of gap junctions. Oxf Rev Reprod Biol 1988;10:436-90.
8. Flint APF, Anderson ABM, Steele PA, Turnbull AC. The mechanism by which foetal cortisol controls the onset of parturition in the sheep. Biochem Soc Trans 1975;3:1189-94.
9. Liggins GC. Initiation of labor. Biol Neonate 1989;55:366-75.
10. Honnebier MB, Nathanielsz PW. Primate parturition and the role of the maternal circadian system. Eur J Obstet Gynecol Reprod Biol 1994;55: 193-203.
11. Nathanielsz PW. Comparative studies on the initiation of labor. Eur J Obstet Gynecol Reprod Biol 1998;78:127-32.
12. Liggins GC. The onset of labour: an overview. In: McNellis D, Challis JRG, MacDonald PC, Nathanielsz PW, Roberts JM, eds. The onset of labor: cellular and integrative mechanisms: a National Institute of Child Health & Human Development Research Planning Workshop, November 29-December 1, 1987. Ithaca, N.Y.: Perinatology Press, 1988:1-3.
13. Liggins GC, Fairclough RJ, Grieves SA, Kendall JZ, Knox BS. The mechanism of initiation of parturition in the ewe. Recent Prog Horm Res 1973;29:111-59.
14. Thorburn GD, Hollingworth SA, Hooper SB. The trigger for parturition in sheep: fetal hypothalamus or placenta? J Dev Physiol 1991;15:71-9.
15. Matthews SG, Challis JRG. Regulation of the hypothalamo-pituitary-adreno-cortical axis in fetal sheep. Trends Endocrinol Metab 1996;4:239-46.
16. Pauerstein CJ, Zauder HL. Autonomic innervation, sex steroids and uterine contractility. Obstet Gynecol Surv 1970;25:Suppl:617-30.
17. Norwitz ER, Robinson JN, Repke JT. The initiation of parturition: a comparative analysis across the species. Curr Probl Obstet Gynecol Infertil 1999;22:41-72.
18. Myers DA, Nathanielsz PW. Biologic basis of term and preterm labor. Clin Perinatol 1993;20:9-28.
19. Rush RW, Keirse MJNC, Howat P, Baum JD, Anderson AB, Turnbull AC. Contribution of preterm delivery to perinatal mortality. BMJ 1976;2: 965-8.
20. Villar J, Ezcurra EJ, de la Fuente VG, Canpodonico L. Pre-term delivery syndrome: the unmet need. Res Clin Forums 1994;16:9-33.
21. Romero R, Avila C, Brekus CA, Morotti R. The role of systemic and intrauterine infection in preterm parturition. Ann N Y Acad Sci 1991;622: 355-75.
22. Dudley DJ. Pre-term labor: an intra-uterine inflammatory response syndrome? J Reprod Immunol 1997;36:93-109.
23. Romero R, Emamian M, Wan M, Quintero R, Hobbins JC, Mitchell MD. Prostaglandin concentrations in amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 1987;157: 1461-7.
24. Elovitz M, Saunders T, Phillippe M. Thrombin, a non-classic uterotonic agonist that produces phasic myometrial contractions. Am J Obstet Gynecol 1999;180:S15. abstract.
25. Creasy RK, Gummer BA, Liggins GC. System for predicting spontaneous preterm birth. Obstet Gynecol 1980;55:692-5.
26. Mercer BM, Goldenberg RL, Das A, et al. The preterm prediction study: a clinical risk assessment system. Am J Obstet Gynecol 1996;174: 1885-93.
27. Iams JD, Johnson FF, O'Shaughnessy RW. A prospective random trial of home uterine activity monitoring in pregnancies at increased risk of preterm labor. Am J Obstet Gynecol 1988;159:595-603.
28. Mortensen OA, Franklin J, Lofstrand T, Svanberg B. Prediction of preterm birth. Acta Obstet Gynecol Scand 1987;66:507-12.
29. Iams JD, Goldenberg RL, Meis PJ, et al. The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med 1996;334:567-72.
30. Heath VCF, Southall TR, Souka AP, Elisseou A, Nicolaides KH. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol 1998;12:312-7.
31. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 1995;333:1737-42.
32. Gibbs RS, Romero R, Hillier SH, Eschenbach DA, Sweet RL. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992;166:1515-28.
33. Sweet RL, Landers DV, Walker C, Schachter J. Chlamydia trachomatis infection and pregnancy outcome. Am J Obstet Gynecol 1987;156:824-33.
34. Moller M, Thomsen AC, Borch K, Dinesen K, Zdravkovic M. Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women. Lancet 1984;2:69-70.
35. Gibbs RS, Eschenbach DA. Use of antibiotics to prevent preterm birth. Am J Obstet Gynecol 1997;177:375-80.
36. Romero R, Yoon BH, Mazor M, et al. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and Gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1993;169:839-51.
37. Petraglia F, De Vita D, Gallinelli A, et al. Abnormal concentration of maternal serum activin-A in gestational diseases. J Clin Endocrinol Metab 1995;80:558-61.
38. Petraglia F. Inhibin, activin and follistatin in the human placenta: a new family of regulatory proteins. Placenta 1997;18:3-8.
39. Lockwood CJ, Senyei AE, Dische MR, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991;325:669-74.
40. Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A, McNellis D. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol 1996;87:643-8.
41. Iams JD, Casal D, McGregor JA, et al. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995;173:141-5.
42. Rajabi M, Dean DD, Woessner IF Jr. High levels of serum collagenase in premature labor: a potential biochemical marker. Obstet Gynecol 1987; 69:179-86.
43. Clark IM, Morrison JJ, Hackett GA, Powell EK, Cawston TE, Smith SK. Tissue inhibitor of metalloproteinases: serum levels during pregnancy and labor, term and preterm. Obstet Gynecol 1994;83:532-7.
44. Hanssens MC, Selby C, Symonds EM. Sex steroid hormone concentrations in preterm labour and the outcome of treatment with ritodrine. Br J Obstet Gynaecol 1985;92:698-702.
45. Goodwin TM. A role for estriol in human labor, term and preterm. Am J Obstet Gynecol 1999;180:S208-S213.
46. Voss HF. Saliva as a fluid for measurement of estriol levels. Am J Obstet Gynecol 1999;180:S226-S231.
47. McGregor JA, Jackson GM, Lachelin GC, et al. Salivary estriol as risk assessment for preterm labor: a prospective trial. Am J Obstet Gynecol 1995;173:1337-42.
48. Heine RP, McGregor JA, Dullien VK. Accuracy of salivary estriol testing compared to traditional risk factor assessment in predicting preterm birth. Am J Obstet Gynecol 1999;180:S214-S218.
49. Petersen LK, Skajaa K, Uldbjerg N. Serum relaxin as a potential market for preterm labour. Br J Obstet Gynaecol 1992;99:292-5.
50. Korebrits C, Ramirez MM, Watson L, Brinkman E, Bocking AD, Chaliis JRG. Maternal corticotropin-releasing hormone is increased with impending preterm birth. J Clin Endocrinol Metab 1998;83:1585-91.
51. Hobel CJ, Dunkel-Schetter C, Rocsch SC, Castro LC, Arora CP. Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery. Am J Obstet Gynecol 1999;180:S257-S263.
52. Goldenberg RL, Cliver SP, Bronstein J, Cutter GR, Andrews WW, Mennemeyer ST. Bed rest in pregnancy. Obstet Gynecol 1994;84:131-6.
53. Fuchs A-R, Fuchs F. Ethanol for prevention of preterm birth. Semin Perinatol 1981;5:236-51.
54. Besinger RE, Niebyl JR. The safety and efficacy of tocolytic agents for the treatment of preterm labor. Obstet Gynecol Surv 1990;45:415-40.
55. Higby K, Xenakis EM-J, Pauerstein CJ. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol 1993;168:1247-59.
56. Hill WC. Risks and complications of tocolysis. Clin Obstet Gynecol 1995;38:725-45.
57. The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992; 327:308-12.
58. Glock JL, Morales WJ. Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: randomized study. Am J Obstet Gynecol 1993;169:960-4.
59. Papatsonis DNM, Van Geijn HP, Adèr HJ, Lange FM, Bleker OP, Dekker GA. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol 1997;90:230-4.
60. Zuckerman H, Shalev E, Gilad G, Katzuni E. Further study of the inhibition of premature labor by indomethacin. II. Double-blind study. J Perinat Med 1984;12:25-9.
61. Norton ME, Merrill J, Cooper BAB, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993;329:1602-7.
62. Morrison JJ, Ashford MLJ, Khan RN, Smith SK. The effects of potassium channel openers on the isolated human myometrium before and after the onset of labor: potential for tocolysis. Am J Obstet Gynecol 1993;169: 1277-85.
63. Andersen LF, Lyndrup J, Akerlund M, Melin F. Oxytocin receptor blockade: a new principle in the treatment of preterm labor? Am J Perinatol 1989;6:196-9.
64. Goodwill TM, Valenzuela G, Silver H, Hayashi R, Creasy GW, Lane R. Treatment of preterm labor with the oxytocin antagonist atosiban. Am J Perinatol 1996;13:143-6.
65. Goodwin TM, Zograbyan A. Oxytocin receptor antagonists: update. Clin Perinatol 1998;25:859-71.
66. Rust OA, Bofill JA, Arriola RM, Andrew ME, Morrison JC. The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol 1996;175:838-42.
67. Guinn DA, Goepfert AR, Owen J, Wenstrom KD, Hauth JC. Terbutaline pump maintenance therapy for prevention of preterm delivery: a double-blind trial. Am J Obstet Gynecol 1998;179:874-8.
68. Ferguson JE II, Hensleigh PA, Kredenster D. Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. Am J Obstet Gynecol 1984;148:166-71.
69. Valenzuela G, Cline S. Use of magnesium sulfate in premature labor that fails to respond to beta-mimetic drugs. Am J Obstet Gynecol 1982; 143:718-9.
70. Allen SR. Tocolytic therapy in preterm PROM. Clin Obstet Gynecol 1998;41:842-8.